In contrast to many other cancer types, there does not appear to be a reciprocal relationship in the loss of INK4a/ARF and P53, pointing to non-overlapping functions for ARF and P53 in pancreatic cancer suppression [189]. This evidence concerns the gene CDKN2A and familial pancreatic carcinoma.